| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/14/2007 | US20070134327 Compositions and methods for improved efficacy of penicillin-type antibiotics |
| 06/14/2007 | US20070134326 Composition for releasing a weak base for an extended period of time |
| 06/14/2007 | US20070134325 Beta-lactam antibiotic-containing tablet and production thereof |
| 06/14/2007 | US20070134324 Therapeutic combinations |
| 06/14/2007 | US20070134323 Ziprasidone suspension |
| 06/14/2007 | US20070134322 Modified and pulsatile release pharmaceutical formulations of escitalopram |
| 06/14/2007 | US20070134320 orally ingested composition for treatment of herpetic epidermal lesions caused by Herpes Simplex Virus, Herpes Zoster, and Herpes Genitalia, consisting of zinc sulfate, magnesium sulfate, thiamine, riboflavin, pyridoxine hydrochloride, ascorbic acid, niacin, pantothenic acid, in tablets or capsules |
| 06/14/2007 | US20070134319 Pharmaceutical formulations of bisphosphonates |
| 06/14/2007 | US20070134317 Non-effervescent form of sodium naproxen comprising i.a. sodium hydrogen carbonate |
| 06/14/2007 | US20070134316 Soft capsule of butylphthalide and a process for preparing the same |
| 06/14/2007 | US20070134315 Orally administrable extended release pellet and tablet formulations of a highly water soluble compound |
| 06/14/2007 | US20070134314 Therapeutic inhibitor of vascular smooth muscle cells |
| 06/14/2007 | US20070134313 Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
| 06/14/2007 | US20070134312 Liposomes for treatment of multiple myeloma |
| 06/14/2007 | US20070134311 External preparation |
| 06/14/2007 | US20070134310 Transdermal risperidone delivery system |
| 06/14/2007 | US20070134309 Agent containing ergoline for transdermal application |
| 06/14/2007 | US20070134308 Non-steroidal anti-inflammatory drug formulations for topical applications to the skin |
| 06/14/2007 | US20070134300 Novel chromium (iii) alpha amino acid complexes |
| 06/14/2007 | US20070134286 Methods for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals |
| 06/14/2007 | US20070134280 Thixotropic ingestible formulation to treat sore throat |
| 06/14/2007 | US20070134278 Aqueous dispersions and solutions of difficult to dissolve materials and methods of their preparation |
| 06/14/2007 | US20070134277 Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms |
| 06/14/2007 | US20070134276 Microemulsions of retinoids, and pharmaceutical compositions containing them |
| 06/14/2007 | US20070134273 Composition and method for the treatment of carcinoma |
| 06/14/2007 | US20070134265 Anti-aging composition and collagen production promoting composition |
| 06/14/2007 | US20070134260 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases |
| 06/14/2007 | US20070134259 Methods and compositions for pharmacologially controlled targeted immunotherapy |
| 06/14/2007 | US20070134255 Hmpv treatment with ribavirin and anti-hmpv antibody |
| 06/14/2007 | US20070134244 Combination treatment for pathologic ocular angiogenesis |
| 06/14/2007 | US20070134239 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 06/14/2007 | US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases |
| 06/14/2007 | US20070134232 Topical bite care composition |
| 06/14/2007 | US20070134231 Method for prolonging activity of autodegradable enzymes and compositions thereof |
| 06/14/2007 | US20070134226 Heparan sulfate glycosaminoglycan lyase and uses thereof |
| 06/14/2007 | US20070134202 Cancer gene therapeutic drug |
| 06/14/2007 | US20070134198 Composition and use of RAR antagonists for promoting chondrogenesis |
| 06/14/2007 | US20070134194 Use of licochalcone A against rosacea |
| 06/14/2007 | US20070134193 Cosmetic and/or pharmaceutical preparations |
| 06/14/2007 | US20070134187 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |
| 06/14/2007 | US20070134183 Aminosulfonic acid compounds for promoting desquamation of the skin |
| 06/14/2007 | US20070134175 Reducing adverse reactions of the skin to chemicals e.g. topical cosmetic; side effect reduction |
| 06/14/2007 | US20070134173 Personal care compositions |
| 06/14/2007 | US20070134172 5-Hydroxy-7-methoxy-2-(4'-methoxyphenyl)-4-oxo-4H-chromen-8-yl]sulfonic acid; plant extracts; use in cosmetic for protecting skin, a pharmaceutical drug, food, or food supplement |
| 06/14/2007 | US20070134166 Airway Alkalinization as Therapy for Airway Diseases |
| 06/14/2007 | US20070134165 Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient |
| 06/14/2007 | US20070134164 Fentanyl composition for nasal administration |
| 06/14/2007 | US20070134161 Methods of determining beta-iii tubulin expression |
| 06/14/2007 | US20070134156 Fatigue evaluation apparatus, fatigue evaluation method, and application thereof |
| 06/14/2007 | US20070134153 Lipid-based drug delivery systems against parasitic infections |
| 06/14/2007 | US20070134136 Disinfecting composition |
| 06/14/2007 | US20070131136 Composition And Process For Coloring Wood |
| 06/14/2007 | DE19936997B4 Verfahren zur Applikation von Photosensibilisatoren (PS) mittels Multiplikatoren in der photodymamischen Therapie A process for the application of photosensitizers (PS) by means of multipliers in the therapy photodymamischen |
| 06/14/2007 | DE102005059750A1 Use of tetraorganosilicon compound having cell proliferation inhibitory activity, e.g. as an immunstimulator to treat viral-, bacterial- and/or tumor diseases, anemia, arteriosclerosis, arthritis, asthma, autoimmune disease, and cirrhosis |
| 06/14/2007 | DE102005059479A1 Hydroxychinolinderivate Hydroxyquinoline |
| 06/14/2007 | DE102005059050A1 Cosmetic-/pharmaceutical composition, useful as hair treatment agent, hair wax or gel wax, and for modeling and/or forming a hairstyle, comprises hydrophobically modified polyol, polysaccharide, emulsifying agent, and fat material |
| 06/14/2007 | DE102005058542A1 Erythruloseester als UV Filter Erythruloseester as UV filters |
| 06/14/2007 | DE102005058369A1 Ungesättigte Fettsäuren als Thrombin-Inhibitoren Unsaturated fatty acids as inhibitors of thrombin |
| 06/14/2007 | DE10103565B4 Zusammensetzungen, enthaltend einen Ruthenium(III)-komplex und einen Heterocyclus Compositions comprising a ruthenium (III) complex and a heterocycle |
| 06/14/2007 | CA2838111A1 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
| 06/14/2007 | CA2812968A1 Pharmaceutical formulation containing phenytoin sodium and magnesium stearate |
| 06/14/2007 | CA2783572A1 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| 06/14/2007 | CA2635378A1 Pharmaceutical compositions and methods for improved bacterial eradication |
| 06/14/2007 | CA2633166A1 Treatment of barrett's esophagus |
| 06/14/2007 | CA2633107A1 Transdermal administration of active agents , in particular diclofenac |
| 06/14/2007 | CA2632813A1 Targeting gli proteins in human cancer by small molecules |
| 06/14/2007 | CA2632719A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions |
| 06/14/2007 | CA2632683A1 Nitric oxide-releasing polymers |
| 06/14/2007 | CA2632673A1 Use of a cb1 antagonist for treating negative symptoms of schizophrenia |
| 06/14/2007 | CA2632669A1 Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or free fatty acid flux |
| 06/14/2007 | CA2632664A1 Composition containing oligosaccharides for the treatment/prevention of infections |
| 06/14/2007 | CA2632653A1 Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof in the treatment of cancer |
| 06/14/2007 | CA2632643A1 Chemical compounds |
| 06/14/2007 | CA2632642A1 Novel diazabicyclic aryl derivatives and their medical use |
| 06/14/2007 | CA2632635A1 Novel inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 06/14/2007 | CA2632568A1 Tetracyclines for treating ocular diseases and disorders |
| 06/14/2007 | CA2632531A1 Propionamide compounds as antiinflammatory agents |
| 06/14/2007 | CA2632512A1 Bicyclic compounds with kinase inhibitory activity |
| 06/14/2007 | CA2632476A1 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
| 06/14/2007 | CA2632395A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 06/14/2007 | CA2632384A1 Methods of preparing a vegf-r inhibitor |
| 06/14/2007 | CA2632280A1 Dioxolane derivates for the treatment of cancer |
| 06/14/2007 | CA2632217A1 Pyridiazinone derivatives for the treatment of tumours |
| 06/14/2007 | CA2632212A1 Plasminogen activator inhibitor-1 inhibitors |
| 06/14/2007 | CA2632200A1 Trioxane dimers having high anticancer and long-lasting antimalarial activities |
| 06/14/2007 | CA2632198A1 Pharmaceutical formulation containing phenytoin sodium and magnesium stearate |
| 06/14/2007 | CA2632109A1 Glucocorticoid receptor modulators as antiinflammatory agents |
| 06/14/2007 | CA2632067A1 Method for improving absorbability of epigallocatechin gallate, foods, drinks and food/drink materials using the same and method for producing the same |
| 06/14/2007 | CA2631936A1 Polymorphs of androgen receptor modulator - (n-3h-imidazo [4 , 5-b] pyridin-2-yl-methyl) -2-fluoro-4-methyl-3-oxo-4-aza-androst- 1-en-17 . beta . -carboxamide |
| 06/14/2007 | CA2631919A1 New process for the preparation of esomeprazole non-salt form |
| 06/14/2007 | CA2631917A1 Quinolone m1 receptor positive allosteric modulators |
| 06/14/2007 | CA2631885A1 Xanthine derivatives, processes for preparing them and their uses |
| 06/14/2007 | CA2631809A1 Bicyclic heteroyclic compounds as antiinflammatory or antiallergic agents |
| 06/14/2007 | CA2631794A1 P38 kinase inhibiting agents |
| 06/14/2007 | CA2631740A1 Methods and compositions for the treatment of disease |
| 06/14/2007 | CA2631643A1 Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| 06/14/2007 | CA2631520A1 Cartilage repair methods |
| 06/14/2007 | CA2631438A1 Trisubstituted quinazolinone derivatives as vanilloid antagonists |
| 06/14/2007 | CA2631364A1 11.beta.-benzaldoxime derivatives of d-homooestra-4,9-dien-3-ones |
| 06/14/2007 | CA2631291A1 Antiproliferative pyrimidyl, fused pyrimidyl and pyridyl hydrazones |